Aurora Cannabis (ACB) Stock Analysis & Winston Score

Aurora Cannabis is a Canadian company that grows and sells cannabis products. Its main products include dried flower, oils, edibles, and vapes sold to medical patients and adult recreational consumers. Aurora operates primarily in Canada but also exports medical cannabis to countries in Europe, Australia, and other markets where medical use is legal. Aurora makes money by selling cannabis products directly to consumers through provincial retailers and to medical patients through its own platform. With a market cap of around $0.2 billion, it is a mid-sized player in a crowded industry that has struggled with oversupply and falling prices since Canada legalized recreational cannabis in 2018. Aurora has built some competitive advantage in the medical cannabis segment, where it has established international distribution relationships, but the company still operates near breakeven with a slightly negative operating margin. The key risk is continued pricing pressure in the Canadian recreational market, while international medical cannabis growth remains the main potential driver.